Reduction of cardiovascular risk in patients with metabolic syndrome in a community health center after a pharmaceutical care program of pharmacotherapy follow-up. Braz. J. Pharm. Sci. 2012;48(3):435-446. doi:10.1590/S1984-82502012000300010